Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-12

Clinical Trial Update: Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 randomized open-label safety trial evaluating the use of a dapivirine vaginal ring with oral TRUVADA during pregnancy has completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapivirine vaginal ring (dapivirine)
  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2025-08-12